Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 32012R0686

Commission Implementing Regulation (EU) No 686/2012 of 26 July 2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of the active substances whose approval expires by 31 December 2018 at the latest Text with EEA relevance

IO L 200, 27.7.2012, p. 5–10 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

Foilsíodh an doiciméad seo in eagrán speisialta (HR)

Legal status of the document In force

ELI: http://data.europa.eu/eli/reg_impl/2012/686/oj

27.7.2012   

EN

Official Journal of the European Union

L 200/5


COMMISSION IMPLEMENTING REGULATION (EU) No 686/2012

of 26 July 2012

allocating to Member States, for the purposes of the renewal procedure, the evaluation of the active substances whose approval expires by 31 December 2018 at the latest

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (1), and in particular Article 19, thereof,

Whereas:

(1)

For active substances whose approval expires by 31 December 2018 at the latest, it is appropriate to allocate the evaluation for the purposes of the renewal procedures to the Member States, naming for each active substance a rapporteur and a co-rapporteur. That allocation should be made in such a way that a balance is achieved as regards the distribution of the responsibilities and the work between Member States.

(2)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,

HAS ADOPTED THIS REGULATION:

Article 1

For the purposes of the renewal procedure, the evaluation of each active substance set out in the first column of the Annex, is allocated to a rapporteur Member State, as set out in the second column of that Annex, and to a co-rapporteur Member State, as set out in the third column of that Annex.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 26 July 2012.

For the Commission

The President

José Manuel BARROSO


(1)   OJ L 309, 24.11.2009, p. 1.


ANNEX

Active substance

Rapporteur Member State

Co-rapporteur Member State

1-methyl-cyclopropene

UK

PT

2,4-DB

BE

EL

Acetamiprid

NL

ES

Alpha-cypermethrin

BE

EL

Amidosulfuron

FI

HR

Ampelomyces quisqualis

Strain: AQ 10

FR

DE

Bacillus subtilis (Cohn 1872)

Strain QST 713, identical with strain AQ 713

DE

DK

Beflubutamid

DE

LT

Benalaxyl

RO

PT

Benthiavalicarb

PL

FR

Benzoic acid

HU

NL

Beta-cyfluthrin

DE

HU

Bifenazate

SE

IT

Bifenox

PL

BE

Bitertanol

SE

CZ

Boscalid

SK

FR

Bromoxynil

FR

DE

Captan

AT

IT

Carbendazim

DE

SI

Carfentrazone ethyl

BE

FR

Carvone

NL

SE

Chloridazon

DE

PL

Chlorothalonil

NL

BE

Chlorotoluron

BG

FR

Chlorpropham

NL

ES

Chlorpyrifos

ES

PL

Chlorpyrifos-methyl

ES

PL

Clodinafop

EL

DE

Clofentezine

ES

NL

Clomazone

DK

DE

Clopyralid

FI

PL

Clothianidin

DE

ES

Coniothyrium minitans

Strain CON/M/91-08 (DSM 9660)

NL

EE

Copper compounds

FR

DE

Cyazofamid

FR

LV

Cyfluthrin

DE

HU

Cypermethrin

BE

DE

Cyprodinil

FR

BG

Daminozide

CZ

HU

Deltamethrin

UK

AT

Desmedipham

FI

DK

Dicamba

DK

RO

Dichlorprop-P

IE

PL

Difenoconazole

ES

UK

Diflubenzuron

EL

SK

Diflufenican

UK

CZ

Dimethenamid-P

DE

BG

Dimethoate

IT

BG

Dimethomorph

PL

DE

Dimoxystrobin

HU

IE

Diuron

DE

DK

Ethephon

NL

PL

Ethofumesate

AT

DK

Ethoprophos

IT

IE

Ethoxysulfuron

IT

AT

Etoxazole

EL

UK

Fenamidone

CZ

FR

Fenamiphos

EL

CY

Fenoxaprop-P

AT

FI

Fenpropidin

CZ

DE

Fipronil

AT

NL

Flazasulfuron

ES

FR

Fludioxonil

FR

ES

Flufenacet

PL

FR

Fluoxastrobin

UK

CZ

Flurtamone

CZ

IE

Folpet

AT

IT

Foramsulfuron

FI

SK

Forchlorfenuron

ES

EL

Formetanate

ES

EL

Fosetyl

FR

EE

Fosthiazate

DE

EL

Gliocladium catenulatum

Strain: J1446

HU

NL

Glufosinate

DE

FR

Imazamox

FR

IT

Imazaquin

BE

IE

Imazosulfuron

SI

FI

Indoxacarb

FR

ES

Iodosulfuron

SE

FI

Ioxynil

FR

AT

Iprodione

FR

BE

Isoxaflutole

IT

SI

Laminarin

NL

FR

Lenacil

BE

AT

Linuron

IT

DE

Maleic hydrazide

DK

BE

Mancozeb

UK

EL

Maneb

IT

UK

MCPA

PL

NL

MCPB

PL

NL

Mecoprop

PL

IE

Mecoprop-P

PL

IE

Mepanipyrim

BE

EL

Mesosulfuron

FR

PL

Mesotrione

UK

BE

Metconazole

BE

UK

Methiocarb

UK

DE

Methoxyfenozide

UK

SK

Metiram

IT

UK

Metrafenone

LV

SK

Metribuzin

EE

DE

Milbemectin

DE

NL

Molinate

EL

PT

Nicosulfuron

LV

NL

Oxadiargyl

PL

IT

Oxadiazon

IT

ES

Oxamyl

IT

FR

Oxasulfuron

IT

AT

Paecilomyces lilacinus (Thom)

Samson 1974 strain 251 (AGAL: No 89/030550)

HU

NL

Pendimethalin

NL

ES

Pethoxamid

AT

CZ

Phenmedipham

FI

DK

Phosmet

ES

EL

Picloram

PL

CZ

Picoxystrobin

CZ

RO

Pirimicarb

UK

SE

Pirimiphos-methyl

UK

FR

Propamocarb

PT

BE

Propiconazole

FI

UK

Propineb

IT

RO

Propoxycarbazone

SE

EE

Propyzamide

SE

UK

Prosulfocarb

PT

SE

Prothioconazole

UK

FR

Pseudomonas chlororaphis

Strain: MA 342

NL

DK

Pyraclostrobin

DE

HU

Pyrimethanil

CZ

AT

Pyriproxyfen

NL

ES

Quinoclamine

SE

DE

Quinoxyfen

UK

AT

Rimsulfuron

SI

FI

Silthiofam

IE

BE

S-metolachlor

DE

FR

Spinosad

NL

FR

Spodoptera exigua nuclear polyhedrosis virus

HU

NL

Tepraloxydim

ES

PL

Thiacloprid

UK

DE

Thiamethoxam

FR

ES

Thiophanate-methyl

SE

FI

Thiram

FR

BE

Tolclofos-methyl

SE

DK

Tribenuron

SE

LV

Triclopyr

PL

HU

Trifloxystrobin

UK

EL

Trinexapac

LT

LV

Triticonazole

AT

UK

Tritosulfuron

SI

AT

Warfarin

SE

DE

Ziram

IT

MT

Zoxamide

LV

FR


Top